University Of North Carolina, Chapel Hill
Clinical trials sponsored by University Of North Carolina, Chapel Hill, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill could stop PTSD before it starts after car crashes Results expected Sep 2026 (estimated)
- Can better sleep after a crash ward off PTSD? Results expected Sep 2026 (estimated)
- Horse program hopes to soothe trauma in veterans and first responders Results expected Sep 2026 (estimated)
- New active rehab program aims to get soldiers back on duty faster after concussion Results expected Sep 2026 (estimated)
- Can a chatbot help young adults lose weight? new study investigates Results expected Sep 2026 (estimated)
-
New acid blocker may offer stronger reflux control for Barrett's esophagus
Disease control Not yet recruitingThis study tests whether vonoprazan, a newer type of acid-suppressing medication, reduces acid reflux in the esophagus better than standard proton pump inhibitors (PPIs) in people with Barrett's esophagus. Participants will first take their usual PPI for a week, then switch to vo…
Phase 4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New hope for EoE patients? drug trial targets those failed by steroids
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already used for other conditions, can help adults with eosinophilic esophagitis (EoE) who still have symptoms despite using topical steroids. Over 12 weeks, 52 participants will take either upadacitinib or a placebo, then all will re…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a diabetes drug curb chronic Pouch-Related bathroom trips?
Disease control Not yet recruitingThis trial tests whether tirzepatide (Zepbound) can reduce daily bowel frequency in adults with an ileal pouch-anal anastomosis (IPAA) who have chronic high bowel frequency despite standard anti-diarrheal therapy. Participants will be assigned to receive tirzepatide or standard c…
Phase 4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Digital coaching may curb binge eating in black women with obesity
Disease control Not yet recruitingThis study tests a 6-month digital program that combines appetite awareness training with behavioral weight loss techniques, delivered remotely via Zoom. It aims to help Black women with obesity who binge eat at least once a week relearn hunger cues and prevent weight gain. The t…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for kids with cashew allergy: daily drops may build tolerance
Disease control Not yet recruitingThis study tests a treatment called sublingual immunotherapy (SLIT) for children ages 1-11 with cashew allergy. For 18 months, children receive daily drops under the tongue to see if they can safely eat more cashew without a reaction. The goal is to reduce allergy severity, not c…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can 'Queen Mothers' bring HIV testing to the doorstep?
Diagnosis Not yet recruitingResearchers are testing whether sex work managers, called queen mothers, can hand out and collect HIV self-tests and self-collected STI test kits at places where female sex workers meet and work in Lusaka. The study compares this peer-supported approach with the current standard …
Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
A baby wrap that fights malaria? a new trial puts treated fabric to the test
Prevention Not yet recruitingThis trial tests whether baby wraps (called lesus) treated with long-lasting insecticide can protect young children from malaria. About 1,300 mothers and their infants (2-4 months old) will be randomly assigned to receive a wrap treated with permethrin, etofenprox, or an untreate…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
New study tests whether extra support during pregnancy can prevent early delivery
Prevention Not yet recruitingThis study tests a personalized support program called PTBCARE+ for pregnant individuals at high risk of delivering early. The program includes a stress reduction toolkit, a website/app, care coordination, and optional massage. Researchers will compare stress levels and birth out…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Can a light bulb dial down chronic pain?
Symptom relief Not yet recruitingResearchers at the University of North Carolina at Chapel Hill are testing whether daily exposure to S-cone stimulating colored light can reduce pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants use programmed ligh…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a 20-Minute brain zap ease depression in pregnancy?
Symptom relief Not yet recruitingThis pilot trial tests whether a single session of personalized brain stimulation, called PandA-tACS, is safe and tolerable for pregnant women with depression. Researchers will compare it to a standard brain stimulation method and a sham (placebo) to see if it changes brain activ…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can a mediterranean diet tame hidradenitis suppurativa?
Symptom relief Not yet recruitingThis pilot study tests whether a 16-week Mediterranean-style diet program is practical and acceptable for adults with hidradenitis suppurativa, a chronic skin condition. All 30 participants receive the same program, which includes video counseling, cooking education, and food sup…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could a daily creatine drink boost postpartum energy and brainpower?
Symptom relief Not yet recruitingResearchers are testing whether taking creatine monohydrate daily for four weeks helps postpartum women improve exercise performance, recover faster after workouts, and sharpen thinking. The trial compares two doses, 5 grams and 10 grams per day, in 40 women who are 6 weeks to 12…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Fish oil pills tested as new hope for jaw pain sufferers
Symptom relief Not yet recruitingThis study tests whether a special omega-3 supplement can reduce pain in adults with chronic temporomandibular disorder (TMD), a condition causing jaw pain. One hundred participants will take either the supplement or a placebo daily for 8 weeks. Researchers will measure changes i…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Healing together: could a Couples-Based program ease ICU aftermath?
Symptom relief Not yet recruitingThis study tests a program called ICU-SUCCEED, designed to help survivors of acute respiratory failure and their family caregivers cope and manage recovery together. The program includes one in-person session and four follow-up sessions by phone or video, focusing on communicatio…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Could an arthritis drug stop asthma attacks in their tracks?
Symptom relief Not yet recruitingThis pilot study tests whether anakinra, a drug that reduces inflammation, can help people with moderate asthma attacks. 60 adults at high risk for asthma attacks will either receive anakinra or a placebo at home when they feel an attack starting. The study will check if this app…
Phase 1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New study tests mindfulness breathing for chronic cough relief
Symptom relief Not yet recruitingThis early-stage study will test if a brief, breath-focused therapy called Acceptance and Commitment Therapy (ACT) is practical and safe for adults with chronic cough. Researchers will enroll 30 people to see if they can stick with the program and find it helpful. The goal is to …
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis study tests whether medications that calm mast cells (ketotifen and cromolyn) can safely reduce persistent symptoms like fatigue, pain, and brain fog in people who had a tick-borne illness. Fifty adults aged 21-65 will receive either one of these drugs or a standard antihist…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Teen brain study: can hormone pills calm suicide risk?
Knowledge-focused Not yet recruitingThis study looks at how natural hormone changes during the menstrual cycle may make some teenage girls more irritable or depressed, especially those at risk for suicide. Researchers will give 50 girls ages 12-16 either a birth control pill to keep hormones steady or a placebo for…
Phase 4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Could exercise be a new way to clear lungs in PCD?
Knowledge-focused Not yet recruitingThis study looks at how exercise and a saltwater mist (hypertonic saline) affect mucus clearance in people with primary ciliary dyskinesia (PCD), a rare lung condition where tiny hairs in the airways don't work properly. Researchers will measure how fast the lungs clear inhaled p…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Which cannabis warnings stick? study puts messages to the test
Knowledge-focused Not yet recruitingThis study aims to find out which cannabis warning messages are most effective at raising awareness and changing perceptions. Researchers will show US adults (both users and non-users) seven different warning messages covering topics like dependence, cognitive function, and cardi…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New study aims to curb Post-Surgery opioid overprescribing
Knowledge-focused Not yet recruitingThis study tests whether a training program helps surgeons and hospital staff reduce the number of opioid painkillers they prescribe after surgery. About 40 healthcare workers and patient representatives from hospitals in North Carolina will take part. The goal is to see if the p…
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC